| Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone® (NCT00836953) | Sanofi Pasteur, a Sanofi Company | 2003-09-01 |
| Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults (NCT00703651) | Sanofi Pasteur, a Sanofi Company | 2003-09-01 |
| Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy (NCT00137579) | Catalan Institute of Health | 2003-09-01 |
| A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination (NCT00835926) | Sanofi Pasteur, a Sanofi Company | 2003-07-01 |
| A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. (NCT00192179) | MedImmune LLC | 2003-06-01 |
| Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months (NCT00192166) | MedImmune LLC | 2002-10-01 |
| Influenza Vaccination in Bone Marrow Transplantation (NCT00419224) | The Cleveland Clinic | 2002-10-01 |
| Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03 (NCT00731029) | GlaxoSmithKline | 2002-09-01 |
| Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024) (NCT00240877) | MedImmune LLC | 2002-08-01 |
| Effectiveness of Influenza Vaccination Among General Practitioners (NCT00221676) | University Hospital, Antwerp | 2002-07-01 |
| Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza (NCT00192413) | MedImmune LLC | 2002-03-01 |
| Development of an Intranasal Proteosome Influenza Vaccine (NCT02522754) | Hvivo | 2002-01-01 |
| Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. (NCT00192426) | MedImmune LLC | 2001-09-01 |
| Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. (NCT00192309) | MedImmune LLC | 2001-09-01 |
| Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children (NCT00192322) | MedImmune LLC | 2001-09-01 |
| Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older (NCT00192153) | MedImmune LLC | 2001-07-01 |
| Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older (NCT00217230) | MedImmune LLC | 2001-04-01 |
| Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) (NCT00192231) | MedImmune LLC | 2001-04-01 |
| Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children (NCT00192491) | MedImmune LLC | 2000-12-01 |
| Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers (NCT00192283) | MedImmune LLC | 2000-09-01 |
| Half-Dose Flu Vaccine Study in Healthy Adults (NCT00006146) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-08-01 |
| Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0) (NCT00192361) | MedImmune LLC | 1999-11-01 |
| Control of Epidemic Influenza Through a School-based Influenza Vaccination Program (NCT00138294) | Baylor College of Medicine | 1998-10-01 |
| Pharma-Pen (Formerly Innoject) Auto-injectory TIV (NCT00335855) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Influenza Immunity Against Pandemic Respiratory Virus (NCT00138281) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Intramuscular Peramivir for the Treatment of Uncomplicated Influenza (NCT00486980) | BioCryst Pharmaceuticals | |
| Study of a Flu Vaccine in Children (NCT00001127) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine (NCT00722774) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children (NCT00900991) | Sinovac Biotech Co., Ltd | |
| Trivalent rHA Dose Escalation Study in Elderly Subjects (NCT00170443) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| High Dose Influenza in Immunosuppressed Subjects (NCT00766285) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents (NCT00900588) | Sinovac Biotech Co., Ltd | |
| CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations (NCT00964951) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza (NCT01063933) | National Institute of Allergy and Infectious Diseases (NIAID) | |